SCHEMBL1552593

SCHEMBL1552593

CC(C)(C)[Si](C)(C)Oc1ccc(/C=C/CO)cc1O[Si](C)(C)C(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 3/20 0.43
ALDH1A1 P00352 1/20 0.42
CYP3A4 P08684 1/20 0.42
RECQL P46063 1/20 0.42
MMP9 P14780 1/20 0.38
DRD2 P14416 1/20 0.38
TUBB1 Q9H4B7 8/20 0.36
KMT2A Q03164 1/20 0.35
TUBB4A P04350 3/20 0.34
TUBB P07437 3/20 0.34
TUBA3C P0DPH7 3/20 0.34
TUBA1B P68363 3/20 0.34
TUBA4A P68366 3/20 0.34
TUBB4B P68371 3/20 0.34
TUBB3 Q13509 3/20 0.34
TUBB2A Q13885 3/20 0.34
TUBB8 Q3ZCM7 3/20 0.34
TUBA3E Q6PEY2 3/20 0.34
TUBA1A Q71U36 3/20 0.34
TUBA1C Q9BQE3 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1552595 1.00 PTGS1 (0.43) PTGS1ALDH1A1CYP3A4RECQLMMP9
SCHEMBL17184026 0.93 PTGS1 (0.51) PTGS1ALDH1A1MMP9DRD2TUBB1
SCHEMBL2552196 0.93 PTGS1 (0.51) PTGS1ALDH1A1MMP9DRD2TUBB1
SCHEMBL31098830 0.93 PTGS1 (0.48) PTGS1ALDH1A1MMP9DRD2TUBB1
SCHEMBL1071168 0.83 DRD2 (0.34) ALDH1A1DRD2TUBB1KMT2ATUBB4A
SCHEMBL23777899 0.80 TUBB1 (0.43) PTGS1ALDH1A1DRD2TUBB1KMT2A
SCHEMBL15757538 0.80 TUBB1 (0.43) PTGS1ALDH1A1DRD2TUBB1KMT2A
SCHEMBL17184004 0.80 TUBB1 (0.43) PTGS1ALDH1A1DRD2TUBB1KMT2A
SCHEMBL7366745 0.80 PREP (0.40) PTGS1ALDH1A1CYP3A4RECQLKMT2A
SCHEMBL7366750 0.80 PREP (0.40) PTGS1ALDH1A1CYP3A4RECQLKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1467967-B1 COMPOUNDS FOR MODULATING CELL PROLIFERATION HOSPITAL FOR SICK CHILDREN (CA) 2011-04-27 EP disclosed
US-7598419-B2 Compounds for modulating cell proliferation HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2009-10-06 US disclosed
US-7563820-B2 Compounds for modulating cell proliferation THE HOSPITAL FOR SICK CHILDREN (CA) 2009-07-21 US disclosed
US-20070243612-A1 Novel Compounds for Modulating Cell Proliferation HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2007-10-18 US disclosed
US-20070197660-A1 Compounds for modulating cell proliferation THE HOSPITAL FOR SICK CHILDREN (CA) 2007-08-23 US disclosed
EP-1727822-A4 NOVEL COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC RES DEV LP (CA) 2007-05-09 EP disclosed
EP-1752446-A2 Compounds for modulating cell proliferation HSC Research and Development Limited Partnership (CA) 2007-02-14 EP disclosed
WO-2007006143-A1 COMPOSITIONS AND METHODS FOR DETECTING TRANSFORMED CELLS THE HOSPITAL FOR SICK CHILDREN (CA) 2007-01-18 WO disclosed
EP-1272457-B9 COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC RES DEV LP (CA) 2006-12-20 EP disclosed
EP-1727822-A1 NOVEL COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC Research and Development Limited Partnership (CA) 2006-12-06 EP disclosed
EP-1453500-A1 STYRYL ACRYLONITRILE COMPOUNDS AND THEIR USE TO PROMOTE MYELOPOIESIS THE HOSPITAL FOR SICK CHILDREN (CA) 2004-09-08 EP disclosed
WO-2004032911-A2 STYRYLACRYLONITRILE COMPOUNDS FOR INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR THE HOSPITAL FOR SICK CHILDREN (CA) 2004-04-22 WO disclosed
US-20040072803-A1 Novel compounds for modulating cell proliferation HSC RESEARCH AND DEVELOPMENT LIMITED (CA) 2004-04-15 US disclosed
WO-2003062190-A1 COMPOUNDS FOR MODULATING CELL PROLIFERATION THE HOSPITAL FOR SICK CHILDREN (CA) 2003-07-31 WO disclosed
US-20030109502-A1 Novel compounds for modulating cell proliferation HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2003-06-12 US disclosed
WO-2003030895-A1 STYRYL ACRYLONITRILE COMPOUNDS AND THEIR USE TO PROMOTE MYELOPOIESIS THE HOSPITAL FOR SICK CHILDREN (CA) 2003-04-17 WO disclosed
EP-1272457-A2 COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC Research and Development Limited Partnership (CA) 2003-01-08 EP disclosed
WO-2001079158-A2 COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2001-10-25 WO disclosed
US-5008471-A Process for the preparation of rooperol ROOPEROL (N.A.) (NL) 1991-04-16 US disclosed
US-4956502-A Process for the preparation of rooperol derivative ROOPEROL (N.A.) NV (AN) 1990-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070243612-A1 Novel Compounds for Modulating Cell Proliferation MKI67, CCNA1, PCNA PTGS1 518/4885ALDH1A1 546/4885CYP3A4 4659/4885
US-20030109502-A1 Novel compounds for modulating cell proliferation MKI67, CCNA1, CCNI PTGS1 161/4885ALDH1A1 178/4885CYP3A4 4427/4885
US-20070197660-A1 Compounds for modulating cell proliferation CCND3, CCNO, WNT3 PTGS1 1737/4885ALDH1A1 2246/4885CYP3A4 3292/4885
US-20040072803-A1 Novel compounds for modulating cell proliferation MKI67, CCNA1, MCL1 PTGS1 158/4885ALDH1A1 179/4885CYP3A4 4285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.